Michaela Bártů

737 total citations
52 papers, 385 citations indexed

About

Michaela Bártů is a scholar working on Molecular Biology, Reproductive Medicine and Oncology. According to data from OpenAlex, Michaela Bártů has authored 52 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 18 papers in Reproductive Medicine and 13 papers in Oncology. Recurrent topics in Michaela Bártů's work include Ovarian cancer diagnosis and treatment (16 papers), Endometrial and Cervical Cancer Treatments (7 papers) and Cancer-related gene regulation (6 papers). Michaela Bártů is often cited by papers focused on Ovarian cancer diagnosis and treatment (16 papers), Endometrial and Cervical Cancer Treatments (7 papers) and Cancer-related gene regulation (6 papers). Michaela Bártů collaborates with scholars based in Czechia, Hungary and United Kingdom. Michaela Bártů's co-authors include Pavel Dundr, Kristýna Němejcová, J. Hojný, Ivana Tichá, Nikola Hájková, Romana Michálková, Radek Jakša, Radoslav Matěj, Miroslav Důra and David Cibula and has published in prestigious journals such as Scientific Reports, Modern Pathology and Laboratory Investigation.

In The Last Decade

Michaela Bártů

46 papers receiving 383 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michaela Bártů Czechia 11 132 125 112 104 82 52 385
Masataka Takenaka Japan 9 133 1.0× 94 0.8× 96 0.9× 43 0.4× 41 0.5× 22 342
S Liang United States 4 174 1.3× 166 1.3× 70 0.6× 84 0.8× 60 0.7× 6 360
Susan Valmadre Australia 7 90 0.7× 102 0.8× 108 1.0× 69 0.7× 38 0.5× 11 319
Ashanti Zampa Italy 13 88 0.7× 158 1.3× 70 0.6× 254 2.4× 52 0.6× 21 517
Asad Haider United States 6 75 0.6× 146 1.2× 65 0.6× 102 1.0× 45 0.5× 13 287
M. Lapresa Italy 10 69 0.5× 294 2.4× 113 1.0× 199 1.9× 42 0.5× 16 420
Diana Lim Singapore 11 77 0.6× 234 1.9× 52 0.5× 211 2.0× 96 1.2× 30 415
Tormund S. Njølstad Norway 8 77 0.6× 160 1.3× 109 1.0× 231 2.2× 46 0.6× 11 386
Keisuke Nishihara Japan 8 123 0.9× 100 0.8× 63 0.6× 77 0.7× 46 0.6× 10 332
Kim McManus United States 9 120 0.9× 134 1.1× 107 1.0× 54 0.5× 69 0.8× 10 396

Countries citing papers authored by Michaela Bártů

Since Specialization
Citations

This map shows the geographic impact of Michaela Bártů's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michaela Bártů with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michaela Bártů more than expected).

Fields of papers citing papers by Michaela Bártů

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michaela Bártů. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michaela Bártů. The network helps show where Michaela Bártů may publish in the future.

Co-authorship network of co-authors of Michaela Bártů

This figure shows the co-authorship network connecting the top 25 collaborators of Michaela Bártů. A scholar is included among the top collaborators of Michaela Bártů based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michaela Bártů. Michaela Bártů is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Krausová, Michaela, Nikola Hájková, J. Hojný, et al.. (2025). Integrating clinicopathological and molecular data to assess the biological behavior of uterine inflammatory myofibroblastic tumors. Pathology - Research and Practice. 270. 155959–155959.
2.
3.
Waldauf, Petr, et al.. (2025). B lymphocytes and tertiary lymphoid structures have a prognostic impact on penile squamous cell carcinoma. The Journal of Pathology Clinical Research. 11(6). e70059–e70059.
4.
Hájková, Nikola, J. Hojný, Romana Michálková, et al.. (2024). Somatic Genomic and Transcriptomic Characterization of Primary Ovarian Serous Borderline Tumors and Low-Grade Serous Carcinomas. Journal of Molecular Diagnostics. 26(4). 257–266. 9 indexed citations
5.
Bártů, Michaela, Romana Michálková, Marián Švajdler, et al.. (2024). The role of stathmin expression in the differential diagnosis, prognosis, and potential treatment of ovarian sex cord-stromal tumors. Diagnostic Pathology. 19(1). 118–118.
6.
Hájková, Nikola, J. Hojný, Jiří Dvořák, et al.. (2024). Unraveling the Molecular Landscape of Uterine Tumor Resembling Ovarian Sex Cord Tumor: Insights From A Clinicopathological, Morphologic, Immunohistochemical, and Molecular Analysis of 35 Cases. Modern Pathology. 37(12). 100611–100611. 6 indexed citations
7.
Michálková, Romana, Nikola Hájková, J. Hojný, et al.. (2024). The Molecular Landscape of 227 Adult Granulosa Cell Tumors of the Ovary: Insights into the Progression from Primary to Recurrence. Laboratory Investigation. 105(3). 102201–102201. 2 indexed citations
8.
Bártů, Michaela, Kristýna Němejcová, Romana Michálková, et al.. (2023). Neuroendocrine Marker Expression in Primary Non-neuroendocrine Epithelial Tumors of the Ovary: A Study of 551 Cases. International Journal of Gynecological Pathology. 43(2). 123–133.
9.
Bártů, Michaela, Kristýna Němejcová, Romana Michálková, et al.. (2023). HER2 status as a potential predictive biomarker for ovarian clear cell carcinoma. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 483(4). 497–507. 6 indexed citations
10.
Dundr, Pavel, Aymara Mas, Michal Mára, et al.. (2023). Uterine leiomyoma with RAD51B::NUDT3 fusion: a report of 2 cases. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 484(6). 1015–1022. 7 indexed citations
11.
Němejcová, Kristýna, Michaela Bártů, Romana Michálková, et al.. (2023). A comprehensive immunohistochemical analysis of 26 markers in 250 cases of serous ovarian tumors. Diagnostic Pathology. 18(1). 32–32. 11 indexed citations
12.
Dundr, Pavel, Michaela Bártů, Martina Zimovjanová, et al.. (2021). Review of tumor infiltrating lymphocytes assessment in breast cancer in routine diagnostic practice.. PubMed. 57(3). 161–166.
13.
Němejcová, Kristýna, Pavel Dundr, Radek Jakša, et al.. (2020). Comprehensive Analysis of PTEN in Primary Cutaneous Melanoma. Folia Biologica. 66(1). 7–16. 4 indexed citations
14.
Dundr, Pavel, Kristýna Němejcová, Michaela Bártů, et al.. (2020). Ovarian mesonephric-like adenocarcinoma arising in serous borderline tumor: a case report with complex morphological and molecular analysis. Diagnostic Pathology. 15(1). 91–91. 35 indexed citations
15.
Dundr, Pavel, Michaela Bártů, J. Hojný, et al.. (2020). HNF1B, EZH2 and ECI2 in prostate carcinoma. Molecular, immunohistochemical and clinico-pathological study. Scientific Reports. 10(1). 14365–14365. 8 indexed citations
16.
Tichá, Ivana, J. Hojný, Romana Michálková, et al.. (2019). A comprehensive evaluation of pathogenic mutations in primary cutaneous melanomas, including the identification of novel loss-of-function variants. Scientific Reports. 9(1). 17050–17050. 36 indexed citations
17.
Dundr, Pavel, Kristýna Němejcová, Michaela Bártů, Ivana Tichá, & Radek Jakša. (2019). [Evaluation of inflammatory cells (tumor infiltrating lymphocytes - TIL) in malignant melanoma].. PubMed. 54(1). 27–31. 1 indexed citations
18.
Bártů, Michaela, Pavel Dundr, Kristýna Němejcová, et al.. (2018). The Role of HNF1B in Tumorigenesis of Solid Tumours: a Review of Current Knowledge. Folia Biologica. 64(3). 71–83. 12 indexed citations
19.
Dundr, Pavel, Kristýna Němejcová, Michaela Bártů, et al.. (2018). Stathmin is a potential therapeutic target but not a prognostic marker in melanoma: an immunohistochemical study of 323 melanocytic lesions. Melanoma Research. 29(2). 157–162. 5 indexed citations
20.
Důra, Miroslav, Kristýna Němejcová, Radek Jakša, et al.. (2017). Expression of Glut-1 in Malignant Melanoma and Melanocytic Nevi: an Immunohistochemical Study of 400 Cases. Pathology & Oncology Research. 25(1). 361–368. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masataka Takenaka Breakdown of academic impact, for papers by S Liang Breakdown of academic impact, for papers by Susan Valmadre Breakdown of academic impact, for papers by Ashanti Zampa Breakdown of academic impact, for papers by Asad Haider Breakdown of academic impact, for papers by M. Lapresa Breakdown of academic impact, for papers by Diana Lim Breakdown of academic impact, for papers by Tormund S. Njølstad Breakdown of academic impact, for papers by Keisuke Nishihara Breakdown of academic impact, for papers by Kim McManus
Rankless by CCL
2026